Prevymis 480 mg Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Prevymis 480 mg Tablet contains letermovir, an antiviral medicine. Its labelling describes it for the treatment of infections caused by cytomegalovirus (CMV). It does not treat colds or infections caused by bacteria or other viruses. It is an oral medicine taken at the same time every day, and it is prescribed in children only for selected conditions.

Active ingredient
Letermovir
Strength
480 mg
Dosage form
Oral tablet
Therapeutic class
Antiviral (CMV DNA terminase complex inhibitor)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of infections caused by cytomegalovirus (CMV)
  • Described as not treating colds or infections caused by bacteria or other viruses
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • An oral medicine taken at the same time every day; the tablet should not be crushed, broken, or chewed
  • Taken with or without food — it can be taken with food if an upset stomach occurs on an empty stomach
  • Taken for the duration prescribed by the doctor and not stopped until the doctor or health team advises
  • Prescribed in children only for selected conditions, with the doctor consulted about precautions

Described Side Effects

Commonly described side effects include:

  • Cough
  • Headache
  • Nausea
  • Fatigue
  • Stomach pain
  • Swelling of the hands, feet, or ankles

The doctor should be consulted immediately if these effects persist.

Precautions

  • Not for treating bacterial or other viral infections
  • Prescribed in children only for selected conditions, with precautions to be taken
  • Not stopped until the doctor or health team advises

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains letermovir and is used for the treatment of infections caused by cytomegalovirus (CMV). SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as an oral tablet taken at the same time every day, with or without food, swallowed whole, for the duration prescribed by the doctor.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services